10.04.2019 • News

Gelest Appoints Jim Whitlock as Chief Operations Officer

Gelest has appointed Jim Whitlock to the newly created position of Chief...
Gelest has appointed Jim Whitlock to the newly created position of Chief Operations Officer. Source: Gelest

US materials science and technology company Gelest has expanded its executive team and appointed Jim Whitlock to the newly created position of Chief Operations Officer (COO).

“Jim has over 30 years of experience in the silicone business, including roles as senior vice president and corporate vice president with Dow Corning in its Core Products Business and Global Manufacturing & Engineering Operations, and he is joining Gelest at a pivotal time,” said Ken Gayer, CEO of Gelest. “The expansion of our senior leadership team reflects Gelest’s commitment to operational excellence and growth as a globally-recognized leading innovator and manufacturer of highly value-added advanced materials.  With Jim’s appointment, we look forward to improving customer satisfaction and operational performance in every respect and accelerating our growth in advanced technology end markets with the support of our partners at New Mountain Capital.”

Before joining Gelest, Whitlock served as vice president of Integrated Supply Chain for Honeywell’s Performance Materials & Technology business Group. He holds a bachelor’s degree from the Ohio State University.

Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.